Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Preventive prophylactic treatment in posttraumatic epilepsy].

A Oliveros-Juste1, V Bertol, A Oliveros-Cid

  • 1Servicio de Neurología, Policlinica Sagasta, Zaragoza, 50006, Espańa. aoliveros@hmservet.insalud.es

Revista De Neurologia
|June 1, 2002
PubMed
Summary

Posttraumatic epilepsy (PTE) affects 2-3% of epilepsy cases. Current antiepileptic drugs show limited prophylactic efficacy for PTE, necessitating research into novel treatments like neuroprotectors and receptor blockers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[OnabotulinumtoxinA in the treatment of atypical odontalgia: description of a clinical case].

Anales del sistema sanitario de Navarra·2019
Same author

Practical application of brief cognitive tests.

Neurologia (Barcelona, Spain)·2015
Same author

[Quality as management tool. Actions to improve efficiency in neurological care].

Neurologia (Barcelona, Spain)·2009
Same author

[Importance and factors related to chronic fatigue in multiple sclerosis].

Neurologia (Barcelona, Spain)·2005
Same author

[Sleep disorders in multiple sclerosis].

Neurologia (Barcelona, Spain)·2004
Same author

[Predicting factors for depression in multiple sclerosis].

Neurologia (Barcelona, Spain)·2004

Area of Science:

  • Neurology
  • Neuroscience
  • Epileptology

Context:

  • Posttraumatic epilepsy (PTE) arises from traumatic brain injury (TBI).
  • Early seizures post-TBI, while not strictly epileptic, are risk factors for developing PTE.
  • PTE affects 5-20% of TBI patients, particularly those with severe injuries.

Purpose:

  • To evaluate the prophylactic efficacy of antiepileptic drugs (AEDs) for PTE.
  • To explore novel therapeutic targets beyond traditional AEDs for PTE prevention.
  • To recommend a risk-factor-based strategy for PTE management.

Summary:

  • Classic AEDs (Phenobarbital, Phenytoin, Carbamazepine, Valproate) lack confirmed prophylactic efficacy against the 'kindling' effect in PTE.
  • Emerging strategies involve lipid peroxidation inhibitors, neuroprotectors (antioxidants), glutamic and NMDA receptor blockers, and apoptosis modulators.

Related Experiment Videos

  • A tailored approach, considering individual risk factors and focusing on AEDs with proven partial seizure efficacy and good tolerability, is advised.

    • Impact:

    • Highlights the limitations of current AEDs in PTE prophylaxis.
    • Identifies promising new drug classes for future PTE therapeutic development.
    • Advocates for personalized medicine in managing PTE risk and treatment.